Efficacy and Safety of Glycoprotein IIb/IIIa Inhibitors on Top of Ticagrelor in STEMI: A Subanalysis of the ATLANTIC Trial

Anne H. Tavenier, Renicus S. Hermanides, Enrico Fabris, Frédéric Lapostolle, Johanne Silvain, Jurrien M. ten Berg, Jens F. Lassen, Leonardo Bolognese, Warren J. Cantor, Ángel Cequier, Mohamed Chettibi, Shaun G. Goodman, Christopher J. Hammett, Kurt Huber, Magnus Janzon, Béla Merkely, Robert F. Storey, Uwe Zeymer, Patrick Ecollan, Jean-Phillipe Collet, Frank F. Willems, Abdourahmane Diallo, Eric Vicaut, Christian W. Hamm, Gilles Montalescot, Arnoud W. J. van 't Hof, Unknown

Open source

DOI
10.1055/s-0039-1700546
Published
2019-11-21
Container
Thrombosis and Haemostasis
Publisher
Georg Thieme Verlag KG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1055/s-0039-1700546,
  title = {Efficacy and Safety of Glycoprotein IIb/IIIa Inhibitors on Top of Ticagrelor in STEMI: A Subanalysis of the ATLANTIC Trial},
  author = {Anne H. Tavenier and Renicus S. Hermanides and Enrico Fabris and Frédéric Lapostolle and Johanne Silvain and Jurrien M. ten Berg and Jens F. Lassen and Leonardo Bolognese and Warren J. Cantor and Ángel Cequier and Mohamed Chettibi and Shaun G. Goodman and Christopher J. Hammett and Kurt Huber and Magnus Janzon and Béla Merkely and Robert F. Storey and Uwe Zeymer and Patrick Ecollan and Jean-Phillipe Collet and Frank F. Willems and Abdourahmane Diallo and Eric Vicaut and Christian W. Hamm and Gilles Montalescot and Arnoud W. J. van 't Hof and Unknown},
  year = {2019},
  journal = {Thrombosis and Haemostasis},
  doi = {10.1055/s-0039-1700546},
  url = {https://doi.org/10.1055/s-0039-1700546}
}

RIS

TY  - JOUR
TI  - Efficacy and Safety of Glycoprotein IIb/IIIa Inhibitors on Top of Ticagrelor in STEMI: A Subanalysis of the ATLANTIC Trial
AU  - Anne H. Tavenier
AU  - Renicus S. Hermanides
AU  - Enrico Fabris
AU  - Frédéric Lapostolle
AU  - Johanne Silvain
AU  - Jurrien M. ten Berg
AU  - Jens F. Lassen
AU  - Leonardo Bolognese
AU  - Warren J. Cantor
AU  - Ángel Cequier
AU  - Mohamed Chettibi
AU  - Shaun G. Goodman
AU  - Christopher J. Hammett
AU  - Kurt Huber
AU  - Magnus Janzon
AU  - Béla Merkely
AU  - Robert F. Storey
AU  - Uwe Zeymer
AU  - Patrick Ecollan
AU  - Jean-Phillipe Collet
AU  - Frank F. Willems
AU  - Abdourahmane Diallo
AU  - Eric Vicaut
AU  - Christian W. Hamm
AU  - Gilles Montalescot
AU  - Arnoud W. J. van 't Hof
AU  - Unknown
PY  - 2019
JO  - Thrombosis and Haemostasis
DO  - 10.1055/s-0039-1700546
UR  - https://doi.org/10.1055/s-0039-1700546
ER  - 

APA

Tavenier, A. H., Hermanides, R. S., Fabris, E., Lapostolle, F., Silvain, J., Berg, J. M. T., Lassen, J. F., Bolognese, L., Cantor, W. J., Cequier, Á., Chettibi, M., Goodman, S. G., Hammett, C. J., Huber, K., Janzon, M., Merkely, B., Storey, R. F., Zeymer, U., Ecollan, P., Collet, J., Willems, F. F., Diallo, A., Vicaut, E., Hamm, C. W., Montalescot, G., Hof, A. W. J. V. '., & Unknown (2019). Efficacy and Safety of Glycoprotein IIb/IIIa Inhibitors on Top of Ticagrelor in STEMI: A Subanalysis of the ATLANTIC Trial. Thrombosis and Haemostasis. https://doi.org/10.1055/s-0039-1700546

Source records